Nadine Clausell Selected Research

Angiotensin II

1/2019

Cardiac hypertrophy in mice submitted to a swimming protocol: influence of training volume and intensity on myocardial renin-angiotensin system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nadine Clausell Research Topics

Disease

40	Heart Failure 01/2022 - 11/2004
5	Myocardial Infarction 01/2019 - 08/2010
4	Anemia 10/2013 - 02/2007
4	Systolic Heart Failure 01/2013 - 09/2009
3	Cardiotoxicity 01/2016 - 04/2005
2	Heart Diseases (Heart Disease) 01/2020 - 03/2014
2	Hypokalemia 01/2015 - 04/2014
2	Heart Arrest (Cardiac Arrest) 01/2015 - 04/2014
2	Hyperkalemia 01/2015 - 04/2014
2	Weight Loss (Weight Reduction) 09/2014 - 06/2013
2	Insulin Resistance 10/2013 - 12/2011
2	Inflammation (Inflammations) 10/2013 - 01/2013
2	Infarction (Infarctions) 08/2013 - 08/2010
2	Iron Deficiencies 01/2013 - 01/2008
2	Neoplasms (Cancer) 12/2011 - 10/2006
2	Ventricular Tachycardia 05/2010 - 09/2008
2	Left Ventricular Dysfunction 02/2006 - 04/2005
1	Bacterial Pneumonia 01/2022
1	Venous Thromboembolism 01/2022
1	Sepsis (Septicemia) 01/2022
1	Aneurysm (Aneurysms) 07/2020
1	Coronary Aneurysm (Aneurysm, Coronary) 07/2020
1	Fistula 07/2020
1	Sarcoidosis (Schaumann Disease) 01/2020
1	Bundle-Branch Block (Fascicular Block) 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Obesity 12/2015
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2015
1	Dyspnea (Shortness of Breath) 01/2015
1	Disease Progression 09/2014
1	Carotid Artery Diseases 02/2014
1	Atherosclerosis 02/2014
1	Hemorrhage 02/2014
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2014
1	Vascular Diseases (Vascular Disease) 11/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2012
1	Prostatic Neoplasms (Prostate Cancer) 12/2011

Drug/Important Bio-Agent (IBA)

6	IronIBA 07/2015 - 02/2007
5	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 12/2011
5	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 12/2011
4	Natriuretic PeptidesIBA 01/2022 - 05/2007
4	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2018 - 12/2010
4	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 02/2011
4	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 10/2013 - 08/2003
3	LipidsIBA 01/2016 - 12/2011
3	CreatinineIBA 01/2015 - 10/2006
3	SodiumIBA 09/2014 - 10/2006
3	Erythropoietin FDA Link 10/2013 - 02/2007
3	AntioxidantsIBA 11/2006 - 08/2003
2	CollagenIBA 02/2014 - 09/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 02/2006
2	Adrenergic Agents (Adrenergic Drugs)IBA 05/2010 - 02/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2007 - 04/2005
2	Superoxide DismutaseIBA 04/2005 - 08/2003
1	Pharmaceutical PreparationsIBA 01/2020
1	angiotensin I (1-7)IBA 01/2019
1	Angiotensin IIIBA 01/2019
1	Advanced Glycation End ProductsIBA 01/2019
1	Proto-Oncogene MasIBA 01/2019
1	Type 1 Angiotensin ReceptorIBA 01/2019
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2018
1	caprolactoneIBA 01/2016
1	NanocapsulesIBA 01/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2016
1	Deferoxamine (Desferal)FDA LinkGeneric 07/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 07/2015
1	Chelating AgentsIBA 07/2015
1	PotassiumIBA 01/2015
1	Dietary SodiumIBA 09/2014
1	Indicators and Reagents (Reagents)IBA 03/2014
1	mouse MIRN29 microRNAIBA 03/2014
1	Hematoxylin (Haematoxylon)IBA 02/2014
1	C.I. direct red 80IBA 02/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2014
1	Vitamin D FDA LinkGeneric 01/2014
1	Ferritins (Ferritin)IBA 10/2013
1	Transferrin (beta 2 Transferrin)IBA 10/2013
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	N 30IBA 10/2013
1	pro-brain natriuretic peptide (1-76)IBA 10/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2013
1	Troponin IIBA 08/2013
1	HepcidinsIBA 01/2013
1	Receptor for Advanced Glycation End ProductsIBA 11/2012
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2012
1	AldosteroneIBA 12/2011
1	Insulin (Novolin)FDA Link 12/2011
1	AlbuminsIBA 12/2011

Therapy/Procedure

9	Therapeutics 01/2020 - 09/2008
5	Heart Transplantation (Grafting, Heart) 12/2020 - 08/2009
2	Stents 07/2020 - 11/2006
2	Cardiac Resynchronization Therapy 01/2020 - 12/2013
2	Intravenous Administration 01/2016 - 01/2008
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2013 - 05/2010
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Resistance Training 01/2020
1	Transplantation 11/2015
1	Heart-Assist Devices 12/2013
1	Radiotherapy 12/2011